Amanda E. Rutten

Amanda E. Rutten serves as a key procurement professional within the Naval Medical Logistics Command, supporting the Department of Defense’s mission to sustain combat-ready medical forces through the acquisition of critical diagnostic, laboratory, and life-sustaining medical systems. She manages complex contract actions for high-priority medical logistics requirements, ensuring timely delivery of advanced equipment and technical services to global operational theaters. Her portfolio primarily encompasses the procurement of analytical laboratory instruments, in-vitro diagnostic substances, and specialized scientific consulting services that enable point-of-care diagnostics and preventive medicine capabilities for Navy and Marine Corps medical units. Rutten collaborates with a diverse range of vendors, including manufacturers of clinical diagnostic equipment, scientific instrumentation firms, and technical service providers specializing in medical systems integration and lifecycle support. While no single contractor dominates her award profile, she consistently engages with both large-capability prime contractors and niche suppliers possessing specialized technical expertise in medical device manufacturing and laboratory automation. Her contracting approach emphasizes performance-based requirements, technical validation, and supply chain resilience to meet expeditionary medical needs. Rutten’s procurement activity reflects a strong preference for open competition, with 100% of her acquisitions conducted without set-aside designations. This indicates a focus on technical merit and capability over socioeconomic classifications, prioritizing mission-critical performance and rapid fielding over targeted small business preferences. While small business participation is not formally incentivized in her portfolio, she maintains compliance with all federal acquisition regulations and may engage small businesses through subcontracting or as part of larger teaming arrangements. Her primary procurement focus lies in NAICS 334516 (analytical laboratory instrument manufacturing) and 325413 (in-vitro diagnostic substance manufacturing), reflecting deep expertise in clinical diagnostics and laboratory automation. She also regularly acquires scientific consulting services under NAICS 541690 and 541990, demonstrating proficiency in procuring technical support for medical system deployment, maintenance, and data-driven diagnostics. Her domain knowledge spans medical device regulation, biotechnology supply chains, and field-deployable diagnostic platforms.